SCHEMBL14036502

SCHEMBL14036502

CCC(Oc1ccc(S(=O)(=O)c2ccc(C)cc2)cc1)c1ccc(S(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.50
▸ HTT P42858 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ TDP1 Q9NUW8 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ PKM P14618 1/20 0.42
▸ CNR1 P21554 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SLC6A9 P48067 1/20 0.40
▸ CNR2 P34972 1/20 0.39
▸ BCHE P06276 2/20 0.39
▸ ACHE P22303 2/20 0.39
▸ IGLV6-57 P01721 1/20 0.38
▸ RAPGEF4 Q8WZA2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13266187 0.96 HTT (0.56) GAAHTTSMN1; SMN2TDP1L3MBTL1
SCHEMBL16361395 0.94 BCHE (0.48) GAAHTTSMN1; SMN2TDP1L3MBTL1
SCHEMBL13266243 0.92 HTT (0.52) GAAHTTSMN1; SMN2TDP1L3MBTL1
SCHEMBL18995785 0.91 BCHE (0.45) GAAHTTSMN1; SMN2TDP1L3MBTL1
SCHEMBL12606484 0.88 HTT (0.40) GAAHTTSMN1; SMN2TDP1L3MBTL1
SCHEMBL13082579 0.87 HTT (0.48) GAAHTTSMN1; SMN2TDP1L3MBTL1
SCHEMBL13668721 0.87 HTT (0.48) GAAHTTSMN1; SMN2TDP1L3MBTL1
SCHEMBL13266190 0.87 HTT (0.48) GAAHTTSMN1; SMN2TDP1L3MBTL1
SCHEMBL13668609 0.87 HTT (0.48) GAAHTTSMN1; SMN2TDP1L3MBTL1
SCHEMBL13953755 0.86 ALDH1A1 (0.48) HTTSMN1; SMN2TDP1L3MBTL1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287646-A1 Polyarylene and Method for Producing the Same SUMITOMO CHEMICAL COMPANY, LIMITED 2008-11-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287646-A1 Polyarylene and Method for Producing the Same CYP1A1, C1R, CBR1 GAA 4049/4885HTT 1126/4885SMN1; SMN2 4161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback